MRSA in hospital children: studying antibiotics and nose bacteria
Part of Infections clinical trials.
This study looks at how antibiotics affect MRSA (a type of staph infection) in the noses of hospitalized children. It may help doctors better understand MRSA to improve treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 1 and 16 years old.
- Your child must be staying in the hospital.
- Your child does not have cancer or a blood disorder.
- Your child is not in the Pediatric Intensive Care Unit (PICU).
- You (parent or legal guardian) must sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at bacteria (especially pneumococcus) in the nose and throat of children. It includes children with ear infections or healthy children, to understand which germs are carried and how they relate to illness.
This study tests whether giving a nasal spray of healthy bacteria to infants can restore good germs in the nose after they receive mupirocin ointment to treat Staph aureus. It aims to bring back a healthy nasal microbiome.
This trial tests a new nose spray called HY-133 to see if it's safe and can clear a common type of staph bacteria from the nose. It is for people who have this bacteria but not the antibiotic-resistant kind.
This study compares two oral antibiotics, TMP-SMX and clindamycin, to see which works better for children with MRSA infections in bones, joints, or head/neck areas. It aims to find the best treatment after initial IV therapy.
This trial tests whether a simple nasal swab can help doctors safely stop unnecessary MRSA antibiotics sooner in people with pneumonia. If the swab shows no MRSA, the antibiotic can be stopped early, which may reduce side effects and drug resistance.
This study looks at how gut bacteria and immune markers relate to respiratory infections in children. It may help doctors understand why some children get sick more often and could lead to better treatments.
Hear when a new NAsal MEthicillin-resistant Staphylococcus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.